SumDU Repository: Browsing DSpace

Browsing by Keywords Durvalumab

Showing results 1 to 2 of 2

Issue Year	Title	Author(s)	Type	Views	Downloads
2023	Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study	Psyrri, A.; Fayette, J. Vynnychenko; Harrington, K.; Gillison, M.; Ahn, M.-J.; Takahashi, S.; Weiss, J.; Machiels, J.-P.; Baxi, S.; Vasilyev, A.; Karpenko, A.; Dvorkin, M.; Hsieh, C.-Y.; Thungappa, S.C.; Segura, P.P.; Vynnychenko, Ihor Oleksandrovych; Haddad, R.; Kasper, S.; Mauz, P.-S.; Baker, V.; He, P.; Evans, B.; Wildsmith, S.; Olsson, R.F.; Yovine, A.; Kurland, J.F.; Morsli, N.; Seiwert, T.Y.	Article	10	13
2023	NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC	de Castro, Gilberto Jr.; Rizvi, Naiyer A.; Schmid, Peter; Syrigos, Konstantinos; Martín, Claudio; Yamamoto, Nobuyuki; Cheng, Ying; Moiseyenko, Vladimir; Summers, Yvonne; Vynnychenko, Ihor Oleksandrovych; Lee, Sung Yong; Bryl, Maciej; Zer, Alona; Erman, Mustafa; Timcheva, Constanta; Raja, Rajiv; Naicker, Kirsha; Scheuring, Urban; Walker, Jill; Mann, Helen; Chand, Vikram; Mok, Tony	Article	37	40